Skip to content
DraconiticResearch
Search Sources API
194,164 studies31 sourcesUpdated 1 h ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

PLOD3 Variably Regulates Diverse Phenotypes in Human Cancer Cells

  1. 1Department of Zoology, College of Life Sciences, Nanjing Agricultural University, Nanjing 210095, China

Abstract

PLOD3 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3) is an essential enzyme that modifies collagen and contributes to collagen assembly and function. PLOD3 expression has been linked to human cancers and patient prognosis, although how PLOD3 regulates tumorigenesis is poorly understood. In this study we first examined the association between PLOD3 expression and human cancer survival and found that, in contrast to previous reports, PLOD3 expression was not significantly correlated with overall survival in cancers. We then studied how decreasing and increasing PLOD3 levels affected the phenotypes of HeLa, HT-1080, and HCT116 cells, three diverse and representative human cancer cell lines. Altering PLOD3 expression elicited a variable effect on the cell cycle and cell migration in the three cell lines. However, increased PLOD3 induced apoptosis, elevated the mitochondrial membrane potential, and reduced the reactive oxygen species (ROS) levels in all three cell lines, whereas decreasing PLOD3 had the opposite effects. Subsequent global mRNA expression analyses revealed changes in biological processes and pathways that were consistent with these phenotypic changes and suggested that apoptosis and mitochondrial metabolism might be two important mechanisms by which PLOD3 regulates cell behaviors.

Related

  1. ZNF217-USP15 signaling loop regulates oncogenic phenotypes in ovarian cancer cells
    A. Ogunsanya, F. Alfaran, S. Basavarajaiah +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. LINC01537 Regulates Malignant Phenotypes and Predicts Prognosis in Breast Cancer, and Its Bioinformatics Analysis.
    Yuetong Guo, Libo Shi
    Journal of biochemical and molecular toxicologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. The Diverse Clinical Spectrum of Noonan Syndrome in Pediatric Endocrinology: From Classical to Atypical Phenotypes
    Sara Aszkiełowicz, Anna Łupińska, Arkadiusz Zygmunt +1
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Diverse Clinical Spectrum of TTN-Truncation Variant Cardiomyopathy: A Case Series Illustrating Asymptomatic, Arrhythmic, Recurrent Takotsubo, and Inflammatory Phenotypes.
    Mehran Jalilzadehbinazar, Craig K Reiss, Shane J LaRue +2
    CureusPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  5. Brain PDGFRβ+ Cells Exhibit Diverse Reactive Phenotypes After Stroke Without Requiring KLF4
    Daniel Manrique‐Castano, Ayman ElAli
    GliaPeer-reviewedCC BYFull textNeurologyEurope PMCPMC
BibTeX
@article{zhang2026plod3,
  title = {{PLOD3 Variably Regulates Diverse Phenotypes in Human Cancer Cells}},
  author = {Xiaoxiao Zhang and Mingmin Zhang and Xue Zhang and Kexin Chen and Yilian Wang and Yan Zeng},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = oct,
  doi = {10.3390/ijms27209336},
  url = {https://www.mdpi.com/1422-0067/27/20/9336},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - PLOD3 Variably Regulates Diverse Phenotypes in Human Cancer Cells
AU  - Xiaoxiao Zhang
AU  - Mingmin Zhang
AU  - Xue Zhang
AU  - Kexin Chen
AU  - Yilian Wang
AU  - Yan Zeng
PY  - 2026
DA  - 2026/10/21
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27209336
UR  - https://www.mdpi.com/1422-0067/27/20/9336
AB  - PLOD3 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3) is an essential enzyme that modifies collagen and contributes to collagen assembly and function. PLOD3 expression has been linked to human cancers and patient prognosis, although how PLOD3 regulates tumorigenesis is poorly understood. In this study we first examined the association between PLOD3 expression and human cancer survival and found that, in contrast to previous reports, PLOD3 expression was not significantly correlated with overall survival in cancers. We then studied how decreasing and increasing PLOD3 levels affected the phenotypes of HeLa, HT-1080, and HCT116 cells, three diverse and representative human cancer cell lines. Altering PLOD3 expression elicited a variable effect on the cell cycle and cell migration in the three cell lines. However, increased PLOD3 induced apoptosis, elevated the mitochondrial membrane potential, and reduced the reactive oxygen species (ROS) levels in all three cell lines, whereas decreasing PLOD3 had the opposite effects. Subsequent global mRNA expression analyses revealed changes in biological processes and pathways that were consistent with these phenotypic changes and suggested that apoptosis and mitochondrial metabolism might be two important mechanisms by which PLOD3 regulates cell behaviors.
SN  - 1422-0067
ER  -